Ovaleap® 900 UI: drug preparation and administration. Instituto Bernabeu

Опубликовано: 19 Сентябрь 2026
на канале: Instituto Bernabeu
83,212
113

https://www.institutobernabeu.com/en/
https://www.institutobernabeu.com/for...

Contains the active substance follitropin alfa. This molecule contains follicle-stimulating hormone (FSH). In women, it helps follicle growth and development and helps to produce oestrogen secretion. In men, it is needed to encourage spermatogenesis.

The main aim in assisted reproduction treatment is controlled ovarian stimulation leading to multiple follicle development.

The required dose of medication will be indicated by your gynaecologist based on the ultrasound scans and blood tests that have been performed (oestradiol and progesterone levels).

It is administered by means of a subcutaneous injection using a pen device. The device must be filled using the cartridge containing the drug before it is injected.